Prevention of Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation).
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. Electronic address: rihal@mayo.edu.
Charanjit S
CS
Rihal
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
Kianoush B
KB
Kashani
D058186:Acute Kidney Injury / Q000517:prevention & control*; D001021:Aortic Valve / Q000000981:diagnostic imaging*; D001024:Aortic Valve Stenosis / Q000628:therapy*; D006328:Cardiac Catheterization / Q000379:methods*; D003287:Contrast Media / Q000009:adverse effects*; D004231:Diuresis / Q000187:drug effects*; D004232:Diuretics / Q000627:therapeutic use*; D005260:Female; D005440:Fluid Therapy / Q000379:methods*; D005665:Furosemide / Q000627:therapeutic use*; D019918:Heart Valve Prosthesis Implantation / Q000379:methods*; D006801:Humans; D008297:Male; D011859:Radiography; D014283:Triiodobenzoic Acids / Q000009:adverse effects*
D003287:Contrast Media; D004232:Diuretics; D014283:Triiodobenzoic Acids; D005665:Furosemide
TAVR; acute kidney injury; contrast nephropathy